Humate-P is the second biological product to be approved for the management of surgery and invasive procedures in patients with vWD in whom the medication desmopressin may not work.

• 是第二个被批准用于去氨加压素可能无效的血管性血友病患者的外科手术和侵入操作的生物制品。